Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
Study NCT ID:
NCT00272012
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2006-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
OPAL - Insulin Glulisine, Diabetes Mellitus
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2006-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-01-02
First Submit QC Date:
None
Study First Post Date:
2006-01-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-12-04
Last Update Post Date:
2009-12-07
Last Update Post Date Type:
ESTIMATED